About BioGenex
BioGenex is a company based in Fremont (United States) founded in 1981. It operates as a B2B and D2C. The company has 84 employees as of March 31, 2022. BioGenex offers products and services including IHC Detection Kits, ISH Probes, and Diagnostic Instruments.
- Headquarter Fremont, United States
- Employees 84 as on 31 Mar, 2022
-
Sectors
Industrial Goods & ManufacturingHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biogenex Life Sciences Private Limited
- Date of Incorporation 09 Mar, 2005
- Jurisdiction Adibatla, Telangana, India
-
Annual Revenue
$2.43 M (USD)13.43as on Mar 31, 2022
-
Net Profit
$229 K (USD)609.37as on Mar 31, 2022
-
EBITDA
$476.96 K (USD)12.11as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
84
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioGenex
BioGenex offers a comprehensive portfolio of products and services, including IHC Detection Kits, ISH Probes, and Diagnostic Instruments.
Kits for detecting antigens in tissue samples for tumor diagnosis.
Probes used for in situ hybridization in molecular research.
Instruments for automated staining and analysis processes.
People of BioGenex
Unlock access to complete
Funding Insights of BioGenex
Detailed funding history for BioGenex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioGenex
Investment portfolio details for BioGenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioGenex
Detailed financials for BioGenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biogenex Comparisons
Peer comparison for BioGenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioGenex
Detailed competitors of BioGenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biogenex
Complete news archive for BioGenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioGenex
BioGenex was founded in 1981.
BioGenex is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
As of Mar 31, 2022, the latest employee count at BioGenex is 84.
Annual revenue of BioGenex is $2.43M as on Mar 31, 2022.
BioGenex develops and supplies reagents, detection kits, and automated instruments for immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescent in situ hybridization (FISH). The company focuses on reliable in vitro diagnostics for tumor analysis and research, serving laboratories globally. Operating from offices in the USA, India, and China, they distribute products through direct sales and partners, emphasizing quality testing and technical support for scientific applications.
BioGenex offers IHC Detection Kits, ISH Probes, and Diagnostic Instruments.